Momenta Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Oncology Drug Candidate M402
04 juin 2012 09h00 HE
|
Momenta Pharmaceuticals
CHICAGO, June 4, 2012 (GLOBE NEWSWIRE) -- Preclinical data for M402, a novel oncology drug candidate being developed by Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), showed that M402 in combination...
Momenta to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
30 mai 2012 08h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
11 mai 2012 08h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 11, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports First Quarter 2012 Financial Results
03 mai 2012 08h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 3, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of First Quarter 2012 Financial Results Conference Call
20 avr. 2012 08h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta to Present at the Barclays Capital Global Healthcare Conference
12 mars 2012 12h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., March 12, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta to Present at the Cowen and Company 32nd Annual Health Care Conference
02 mars 2012 15h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., March 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta to Present at the 2012 Citi Global Health Care Conference
24 févr. 2012 16h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta to Present at the Leerink Swann 2012 Global Healthcare Conference
13 févr. 2012 17h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011
09 févr. 2012 08h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...